| Schedule of Number and Weighted Average Exercise Prices of Other Equity Instruments |
The following table summarizes the changes in the Company’s equity-settled RSUs and pRSUs outstanding during the years ended December 31, 2025 and 2024: | | | | | | | | | | Number of
RSUs | Number of
pRSUs | Outstanding – December 31, 2023 | 2,204,498 | | 3,050,646 | | | Granted | 1,151,110 | | 396,900 | | | Settled | (684,819) | | (153,355) | | | Forfeited | (121,250) | | (242,255) | | Outstanding – December 31, 2024 | 2,549,539 | | 3,051,936 | | | Granted | 1,317,913 | | 434,700 | | | Settled | (1,952,191) | | (1,364,297) | | | Forfeited | (109,459) | | (359,466) | | Outstanding – December 31, 2025 | 1,805,802 | | 1,762,873 | |
The following table summarizes the changes in the Company’s cash-settled RSUs and pRSUs outstanding during the years ended December 31, 2025 and 2024: | | | | | | | | | | Number of
RSUs | Number of
pRSUs | Outstanding – December 31, 2023 | 899,667 | | 737,200 | | | Granted | 650,400 | | 43,800 | | | Settled | (305,631) | | — | | | Forfeited | (149,001) | | (72,000) | | Outstanding – December 31, 2024 | 1,095,435 | | 709,000 | | | Granted | 685,300 | | 96,200 | | | Settled | (459,779) | | (580,000) | | | Forfeited | (142,588) | | (107,800) | | Outstanding – December 31, 2025 | 1,178,368 | | 117,400 | |
The following table summarizes the changes in the Company’s DSUs outstanding during the years ended December 31, 2025 and 2024: | | | | | | | Number of
DSUs | Outstanding – December 31, 2023 | 332,242 | | | Granted | 87,545 | | | Redeemed | (32,646) | | Outstanding – December 31, 2024 | 387,141 | | | Granted | 73,226 | | | Redeemed | (158,542) | | Outstanding – December 31, 2025 | 301,825 | |
|
| Schedule of Number and Weighted Average Exercise Prices of Share Options |
The following table summarizes the changes in the Company’s stock options outstanding during the years ended December 31, 2025 and 2024: | | | | | | | | | | | | | Note | Number of options | Weighted
average exercise
price (C$) | Outstanding – December 31, 2023 | | 1,097,150 | | $ | 5.64 | | | Exercised | | (636,024) | | 5.23 | | | Expired/forfeited | | (38,998) | | 5.12 | | Outstanding – December 31, 2024 | | 422,128 | | 6.31 | | | Issued in connection with Calibre Acquisition | 5(a) | 9,882,760 | | 4.04 | | | Exercised | | (2,258,949) | | 3.90 | | | Expired/forfeited | | (246,331) | | 10.33 | | Outstanding and exercisable – December 31, 2025 | | 7,799,608 | | $ | 3.99 | |
|
| Schedule of Share Based Compensation |
The following table summarizes the Company’s share-based compensation for continuing operations recognized during the years ended December 31, 2025 and 2024: | | | | | | | | | | 2025 | 2024 | | RSUs and pRSUs | $ | 25,112 | | $ | 12,416 | | | DSUs | 3,856 | | 480 | | | Stock options | 318 | | — | | | Total share-based compensation | $ | 29,286 | | $ | 12,896 | | | | | | Recognized in the consolidated financial statements as follows: | | | | Equity-settled | | | | General and administration expense | $ | 14,305 | | $ | 9,258 | | | Operating expense | 312 | | 150 | | | Capitalized within construction-in-progress | — | | 690 | | | Cash-settled | | | | General and administration expense | 4,720 | | 538 | | | Operating expense | 5,357 | | 2,260 | | | Care and maintenance expense | 4,592 | | — | | | Total share-based compensation | $ | 29,286 | | $ | 12,896 | |
|